These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 12711473)
1. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473 [TBL] [Abstract][Full Text] [Related]
2. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Kenerson HL; Aicher LD; True LD; Yeung RS Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518 [TBL] [Abstract][Full Text] [Related]
3. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas. Robb VA; Astrinidis A; Henske EP Mod Pathol; 2006 Jun; 19(6):839-46. PubMed ID: 16575396 [TBL] [Abstract][Full Text] [Related]
4. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917 [TBL] [Abstract][Full Text] [Related]
5. The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. Lesma E; Sirchia SM; Ancona S; Carelli S; Bosari S; Ghelma F; Montanari E; Di Giulio AM; Gorio A Am J Pathol; 2009 Jun; 174(6):2150-9. PubMed ID: 19443708 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809 [TBL] [Abstract][Full Text] [Related]
8. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Plank TL; Logginidou H; Klein-Szanto A; Henske EP Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994 [TBL] [Abstract][Full Text] [Related]
9. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation. Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404 [TBL] [Abstract][Full Text] [Related]
15. Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress. Siroky BJ; Yin H; Babcock JT; Lu L; Hellmann AR; Dixon BP; Quilliam LA; Bissler JJ Am J Physiol Renal Physiol; 2012 Sep; 303(6):F831-44. PubMed ID: 22791333 [TBL] [Abstract][Full Text] [Related]
16. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation. Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396 [TBL] [Abstract][Full Text] [Related]
17. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Inoki K; Li Y; Zhu T; Wu J; Guan KL Nat Cell Biol; 2002 Sep; 4(9):648-57. PubMed ID: 12172553 [TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Henske EP Pediatr Nephrol; 2005 Jul; 20(7):854-7. PubMed ID: 15856327 [TBL] [Abstract][Full Text] [Related]
19. Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis. Adachi H; Majima S; Kon S; Kobayashi T; Kajino K; Mitani H; Hirayama Y; Shiina H; Igawa M; Hino O Oncogene; 2004 Apr; 23(19):3495-500. PubMed ID: 14990989 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]